NOT-FD-18-010: Update in Funds Application Due Date(s) & Expiration Date Sections of RFA-FD-08-019 - Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems (U01)

Update in Funds Application Due Date(s) & Expiration Date Sections of RFA-FD-08-019 - Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems (U01)

Notice Number: NOT-FD-18-010

Key Dates
Release Date: April 24, 2018

Related Announcements
RFA-FD-18-019

Issued by
U.S. Food and Drug Administration (FDA)

Purpose

FDA's RFA-FD-18-019 - Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems (U01)has made updates to its sections on page 2 & 3 titled " Application Due Date(s) and Expiration Date ". See revised sections below:

Application Due Date(s)

May 29, 2018, by 11:59 PM Eastern Time.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.

Late applications will not be accepted for this FOA.

Expiration Date

May 30, 2018

Inquiries

Please direct all inquiries to:

Eleftheria Tsakalozou, PhD
DQMM/ORS/OGD/CDER/FDA
Telephone: 240-402-2726
Eleftheria.tsakalozou@fda.hhs.gov